Order byBest matchMost fresh
STAT10h
Pharmalittle: We’re reading about Roche and Sanofi reactions to Trump, R&D rankings, and more
Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the United States
Biopharma giant Roche pledges 420-job factory in fast-growing Wake County town
The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create these jobs between 2028 and 2032 at an average yearly salary of at least $119,800.
Roche boosts US presence with new $700 million North Carolina facility
Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United States amid President Donald Trump's tariff policies.
BioSpace1d
Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.
Daily Journal2d
Roche Diagnostics to invest up to $550M in Indianapolis, adding hundreds of local jobs
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit.
Explore more
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma’s “next generation” weight loss drug.
BioSpace2d
Roche’s Genentech Earmarks $700M for North Carolina Plant as Billion-Dollar US Pledge Hangs in Balance
The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that could change if certain yet-unspecified policies are implemented that could “harm our industry’s ability to operate and innovate in America.
AS Monaco and Roche Bobois extend their partnership until 2027
AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international reputation, are delighted to announce the extension of their partnership for a
Medical Device Network on MSN14h
FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC
The US Food and Drug Administration (FDA) has granted approval to Roche's VENTANA MET (SP44) RxDx Assay to help determine the expression of mesenchymal-epithelial transition factor (MET or c-Met) protein in patients with non-squamous non-small cell lung cancer (NSQ-NSCLC).
Feedback